A novel human prostate-specific gene-1 (HPG-1): Molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis

Cancer Research

Volumn 63, Issue 2, 2003, Pages 329-336

  Herness, Elizabeth A ^a   Naz, Rajesh K ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; OLIGONUCLEOTIDE;

ARTICLE; CANCER DIAGNOSIS; CANCER THERAPY; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA LIBRARY; DNA MODIFICATION; DNA TRANSCRIPTION; EARLY DIAGNOSIS; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENE STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN PROSTATE SPECIFIC GENE 1; HYDROPHILICITY; IN VITRO STUDY; MOLECULAR CLONING; MOLECULAR WEIGHT; MYRISTYLATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; OPEN READING FRAME; ORGAN GROWTH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; SOUTHERN BLOTTING;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL ADHESION MOLECULES; CELL DIVISION; CLONING, MOLECULAR; DIHYDROTESTOSTERONE; DNA, COMPLEMENTARY; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037439924     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A., Rosenberg, H. M., Feigal, E. G., and Edwards, B. K. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst., 93: 824-842, 2001.
2. Ahmed, M. M., Lee, C. T., and Oesterling, J. E. Current trend in the epidemiology of prostatic disease: benign hyperplasia and adenocarcinoma. In: R. K. Naz (ed.), Prostate: Basic and Clinical Aspects, pp. 3-25. Boca Raton, Florida: CRC Press, 1997.
3. Abate-Shen, C., and Shen, M. M. Molecular genetics of prostate cancer. Genes Dev., 14: 2410-2434, 2000.
4. Crawford, E., DeAntoni, E., and Ross, C. The role of prostate-specific antigen in the chemoprevention of prostate cancer. J. Cell. Biochem., 25(Suppl.): 149-155, 1996.
5. vanLersel, M. P., Witjes, W. P., de la Rosette, J. J., and Oosterhof, G. O. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis. Br. J. Urol., 76: 47-53, 1995.
6. Jung, K., Meyer, A., Lein, M., Rudolph, B., Schnorr, D., and Loening, S. A. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J. Urol., 159: 1595-1598, 1998.
7. Herness, E. A., and Naz, R. K. Prostate-specific genes: present status and future direction. Front. Biosci., 6: d1083-d1088, 2001.
8. Shen, R., Su, Z-Z., Olsson, C., and Fisher, P. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc. Natl. Acad. Sci. USA, 92: 6778-6782, 1995.
9. Bussemakers, M. J., van Bokhoven, A., Verhaegh, G. W., Smit, F. P., Karthaus, H. F., Schalken, J. A., Debruyne, F. M., Ru, N., and Isaacs, W. B. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res., 59: 5975-5979, 1999.
10. Srikantan, V., Zou, Z., Petrovics, G., Xu, L., Augustus, M., Davis, L., Livezey, J. R., Connell, T., Sesterhenn, I. A., Yoshino, K., Buzard, G. S., Mostofi, F. K., McLeod, D. G., Moul, J. W., and Srivastava, S. PCGEMI, a prostate-specific gene, is over-expressed in prostate cancer. Proc. Natl. Acad. Sci. USA, 97: 12216-12221, 2000.
11. He, W. W., Sciavolino, P. J., Wing, J., Augustus, M., Hudson, P., Meissner, P. S., Curtis, R. T., Shell, B. K., Bostwick, D. G., Tindall, D. J., Gelmann, E. P., Abate-Shen, C., and Carter, K. C. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics, 43: 69-77, 1997.
12. Oettgen, P., Finger, E., Sun, Z., Akbarali, Y., Thamrongsak, U., Boltax, J., Grall, F., Dube, A., Weiss, A., Brown, L., Quinn, G., Kas, K., Endress, G., Kunsch, C., and Libermann, T. A. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem., 275: 1216-1225, 2000.
13. Xu, L. L., Stackhouse, B. G., Florence, K., Zhang, W., Shanmugam, N., Sesterhenn, I. A., Zou, Z., Srikantan, V., Augustus, M., Roschke, V., Carter, K., McLeod, D. G., Moul, J. W., Soppett, D., and Srivastava, S. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res., 60: 6568-6572, 2000.
14. Wolfgang, C. D., Essand, M., Vincent, J. J., Lee, B., and Pastan, I. TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor γ chain locus. Proc. Natl. Acad. Sci. USA, 97: 9437-9442, 2000.
15. Liu, X. F., Olsson, P., Wolfgang, C. D., Bera, T. K., Duray, P., Lee, B., and Pastan, I. PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon. Prostate, 47: 125-131, 2001.
16. Paoloni-Giacobino, A., Chen, H., Peitsch, M. C., Rossier, C., and Antonarakis, S. E. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane. LDLRA, and SRCR domains and maps to 21q22.3. Genomics. 44: 309-320, 1997.
17. Reiter, R., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le, B. M., Loda, M., and Witte, O. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA, 95: 1735-1740, 1998.
18. Nelson, P., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., and Wang, K. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc. Natl. Acad. Sci. USA, 96: 3114-3119, 1999.
19. Tsavaler, L., Shapero, M. H., Morkowski, S., and Laus, R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res., 61: 3760-3769, 2001.
20. Hubert, R. S., Vivanco, I., Chen, E., Rastegar, S., Leong, K., Mitchell, S. C., Madraswala, R., Zhou, Y., Kuo, J., Raitano, A. B., Jakobovits, A., Saffran, D. C., and Afar, D. E. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA, 96: 14523-14528, 1999.
21. Lin, B., White, J. T., Ferguson, C., Bumgamer, R., Friedman, C., Trask, B., Ellis, W., Lange, P., Hood, L., and Nelson, P. S. PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12. Cancer Res., 60: 858-863, 2000.
22. Xu, J., Kalos, M., Stolk, J. A., Zasloff, E. J., Zhang, X., Houghton, R. L., Filho, A. M., Nolasco, M., Badaro, R., and Reed, S. G. Identification and characterization of prostein, a novel prostate-specific protein. Cancer Res., 61: 1563-1568, 2001.
23. Xu, L. L., Shanmugam, N., Segawa, T., Sesterhenn, I. A., McLeod, D. G., Moul, J. W., and Srivastava, S. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics, 66: 257-263, 2000.
24. Xia, C., Ma, W., Wang, F., Hua, S., and Liu, M. Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene, 20: 5903-5907, 2001.
25. Correale, P., Walmsley, K., Zaremba, S., Zhu, M., Schlom, J., and Tsang, K. Y. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. J. Immunol., 161: 3186-3194, 1998.
26. Murphy, G. P., Tjoa, B. A., Simmons, S. J., Jarisch, J., Bowes, V. A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Cobb, O. E., Ireton, R. C., Troychak, M. J., Salgaller, M. L., and Boynton, A. L. Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase 11 prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. Prostate, 38: 73-78, 1999.
27. Valone, F. H., Small, E., MacKenzie, M., Burch, P., Lacy, M., Peshwa, M. V., and Laus, R. Dendritic cell-based treatment of cancer: closing in on a cellular therapy. Cancer J., 7(Suppl. 2): S53-61, 2001.
28. Santhanam, R., and Naz, R. K. Novel human testis-specific cDNA: molecular cloning, expression, and immunological effects of the recombinant protein. Mol. Reprod. Dev., 60: 1-12, 2001.
29. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. Basic local alignment search tool. J. Mol. Biol., 215: 403-410, 1990.
30. Kyte, J., and Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol., 157: 105-132, 1982.
31. Engelman, D. M., Steitz, T. A., and Goldman, A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. Chem., 15: 321-353, 1986.
32. Zhu, X., and Naz, R. K. Fertilization antigen-1: cDNA cloning, testis-specific expression, and immunocontraceptive effects. Proc. Natl. Acad. Sci. USA, 94: 4704-4709, 1997.
33. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
34. Celi, F. S., Zenilman, M. E., and Shuldiner, A. R. A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res., 21: 1047, 1993.
35. Willey, J. C., Crawford, E. L., Jackson, C. M., Weaver, D. A., Hoban, J. C., Khuder, S. A., and DeMuth, J. P. Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am. J. Respir. Cell. Mol. Biol., 19: 6-17, 1998.
36. Allen, J. T., Knight, R. A., Bloor, C. A., and Spiteri, M. A. Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am. J. Respir. Cell. Mol. Biol., 21: 693-700, 1999.
37. Kozak, M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell. Biol., 115: 887-903, 1991.
38. Kozak, M. Do the 5′ untranslated domains of human cDNAs challenge the rules for initiation of translation (or is it vice versa)? Genomics, 70: 396-406, 2000.
39. van der Velden, A. W., and Thomas, A. A. The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int. J. Biochem. Cell Biol., 31: 87-106, 1999.
40. El-Alfy, M., Moshonas, D., Morales, C. R., and Oko, R. Molecular cloning and developmental expression of the major fibrous sheath protein (FS 75) of rat sperm. J. Androl., 20: 307-318, 1999.
41. Hunter, T. Signaling-2000 and beyond. Cell, 100: 113-127, 2000.
42. Barinaga, M. New clues to how proteins link up to run the cell. Science (Wash. DC), 283: 1247, 1249, 1999.
43. Pawson, T. Protein modules and signaling network. Nature (Lond.), 373: 573-580, 1995.
44. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
45. Steiner, M. S. Peptide growth factors in prostate cancer. In: R. K. Naz (ed.), Prostate: Basic and Clinical Aspects, pp. 151-179. Boca Raton, Florida: CRC Press, 1997.
46. Sattler, H. P., Lensch, R., Rohde, V., Zimmer, E., Meese, E., Bonkhoff, H., Retz, M., Zwergel, T., Bex, A., Stoeckle, M., and Wullich, B. Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. Prostate, 45: 207-215, 2000.
47. Pienta, K. J., and Panvichian, R. Current and future therapies for prostate cancer. In: R. K. Naz (ed.), Prostate: Basic and Clinical Aspects, pp. 345-359. Boca Raton, Florida: CRC Press, 1997.